{"id":"W4245222417","doi":"10.5489/cuaj.609","title":"Emerging novel therapies in the treatment of castrate-resistant prostate cancer","year":2013,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Denosumab; Docetaxel; Cabazitaxel; Prostate cancer; Hormonal therapy; Oncology; Ipilimumab; Combination therapy; Internal medicine; Enzalutamide; Nivolumab; Pharmacology; Cancer; Immunotherapy; Androgen deprivation therapy; Androgen receptor; Osteoporosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001192904,0.0004549649,0.0008296201,0.001180189,0.0003504744,0.001137077,0.0007239629,0.000703325,0.00407146],"category_scores_gemma":[0.0005940347,0.0001697872,0.000548544,0.0008987619,0.0005968861,0.001086381,0.0006531741,0.0021572,0.0009021732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001014303,"about_ca_system_score_gemma":0.00143229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001597077,"about_ca_topic_score_gemma":0.01089412,"domain_scores_codex":[0.9995885,0.0001095227,0.00003717959,0.00003385312,0.0001715567,0.0000592658],"domain_scores_gemma":[0.999643,0.0001130056,0.00006678748,0.00001065101,0.000109455,0.00005713784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002973378,0.0003256932,0.0007845658,0.006625424,0.00008813874,0.001028628,0.0001848656,0.0007045292,0.006046874,0.008213453,0.01975693,0.9559438],"study_design_scores_gemma":[0.0003430915,0.001398433,0.004112664,0.00362408,0.000213361,0.003794589,0.0003601942,0.000884646,0.002643547,0.008182629,0.9743983,0.0000443394],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001802607,0.9898948,0.000553715,0.003044725,0.0005662927,0.00002274719,0.00002771875,0.00001814014,0.004069344],"genre_scores_gemma":[0.01066923,0.9833153,0.001920296,0.001426675,0.0008456912,0.00002158693,0.0000690878,0.000004655999,0.00172746],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00407146,"threshold_uncertainty_score":0.01362044,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02888160460853816,"score_gpt":0.2941673395249527,"score_spread":0.2652857349164145,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}